These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 35898126)

  • 21. Initial immune response after exposure to
    Aiello A; Najafi-Fard S; Goletti D
    Front Immunol; 2023; 14():1244556. PubMed ID: 37662901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The need for protecting and enhancing TB health policies and services for forcibly displaced and migrant populations during the ongoing COVID-19 pandemic.
    Knipper M; Sedas AC; Keshavjee S; Abbara A; Almhawish N; Alashawi H; Lecca L; Wilson M; Zumla A; Abubakar I; Orcutt M
    Int J Infect Dis; 2021 Dec; 113 Suppl 1():S22-S27. PubMed ID: 33775886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Turning threats into opportunities: how to implement and advance quality TB services for people with HIV during the COVID-19 pandemic and beyond.
    Roberts T; Sahu S; Malar J; Abdullaev T; Vandevelde W; Pillay YG; Fujiwara PI; Reid A; Hader S; Singh S; Kamarulzaman A; Ahmedov S
    J Int AIDS Soc; 2021 Apr; 24(4):e25696. PubMed ID: 33787058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 and tuberculosis: the double whammy of respiratory pathogens.
    Shariq M; Sheikh JA; Quadir N; Sharma N; Hasnain SE; Ehtesham NZ
    Eur Respir Rev; 2022 Jun; 31(164):. PubMed ID: 35418488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of COVID-19 on paediatric TB service delivery and patients' comfort receiving TB services in Cameroon and Kenya during COVID: a qualitative assessment.
    Mbunka MA; Katirayi L; McCormick S; Ndimbii J; Masaba R; Denoeud-Ndam L; Petnga SJ; Ouma M; Kuate A; Okomo G; Simo L; Yara D; Tiam A; Tchounga B
    BMJ Open Respir Res; 2024 Jul; 11(1):. PubMed ID: 39074960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 -Tuberculosis interactions: When dark forces collide.
    Udwadia ZF; Vora A; Tripathi AR; Malu KN; Lange C; Sara Raju R
    Indian J Tuberc; 2020 Dec; 67(4S):S155-S162. PubMed ID: 33308662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First case series and literature review of coronavirus disease 2019 (COVID-19) associated pulmonary tuberculosis in Southeast Asia: Challenges and opportunities.
    Siranart N; Sowalertrat W; Sukonpatip M; Suwanpimolkul G; Torvorapanit P
    J Infect Public Health; 2023 Jan; 16(1):80-89. PubMed ID: 36495816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Coronavirus Disease Pandemic on Tuberculosis Notifications, Malawi.
    Soko RN; Burke RM; Feasey HRA; Sibande W; Nliwasa M; Henrion MYR; Khundi M; Dodd PJ; Ku CC; Kawalazira G; Choko AT; Divala TH; Corbett EL; MacPherson P
    Emerg Infect Dis; 2021 Jul; 27(7):1831-1839. PubMed ID: 34152962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of COVID-19 pandemic on incidence of mycobacterial diseases among suspected tuberculosis pulmonary patients in Tehran, Iran.
    Aghajani J; Farnia P; Farnia P; Ghanavi J; Saif S; Marjani M; Tabarsi P; Moniri A; Abtahian Z; Hoffner S; Velayati AA
    Int J Mycobacteriol; 2022; 11(4):415-422. PubMed ID: 36510928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of COVID-19 for delaying the diagnosis and treatment of pulmonary tuberculosis-Tianjin, China.
    Zhang G; Yu Y; Zhang W; Shang J; Chen S; Pang X; Oeltmann JE; Moonan PK; Chen M; Zhang F
    Front Public Health; 2022; 10():937844. PubMed ID: 36530737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrating health planning and primary care infrastructure for COVID-19 and tuberculosis care in India: Challenges and opportunities.
    Yadav P; Vohra C; Gopalakrishnan M; Garg MK
    Int J Health Plann Manage; 2022 Mar; 37(2):632-642. PubMed ID: 34820907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19: A Syndemic Requiring an Integrated Approach for Marginalized Populations.
    Caron RM; Adegboye ARA
    Front Public Health; 2021; 9():675280. PubMed ID: 34046392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Social Distance in COVID-19: Drawing the line between protective behavior and stigma manifestation.
    Economou M
    Psychiatriki; 2021 Sep; 32(3):183-186. PubMed ID: 34390552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 and syndemic challenges in 'Battling the Big Three': HIV, TB and malaria.
    Velavan TP; Meyer CG; Esen M; Kremsner PG; Ntoumi F;
    Int J Infect Dis; 2021 May; 106():29-32. PubMed ID: 33781904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential impact of the COVID-19 response related lockdown on TB incidence and mortality in India.
    Bhargava A; Shewade HD
    Indian J Tuberc; 2020 Dec; 67(4S):S139-S146. PubMed ID: 33308660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tuberculosis management in India during COVID-19 crisis.
    Awasthi AK; Singh PK
    J Public Health Policy; 2021 Mar; 42(1):185-189. PubMed ID: 33235251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concurrent cavitary pulmonary tuberculosis and COVID-19 pneumonia with in vitro immune cell anergy.
    Musso M; Di Gennaro F; Gualano G; Mosti S; Cerva C; Fard SN; Libertone R; Di Bari V; Cristofaro M; Tonnarini R; Castilletti C; Goletti D; Palmieri F
    Infection; 2021 Oct; 49(5):1061-1064. PubMed ID: 33454928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC).
    Ong CWM; Migliori GB; Raviglione M; MacGregor-Skinner G; Sotgiu G; Alffenaar JW; Tiberi S; Adlhoch C; Alonzi T; Archuleta S; Brusin S; Cambau E; Capobianchi MR; Castilletti C; Centis R; Cirillo DM; D'Ambrosio L; Delogu G; Esposito SMR; Figueroa J; Friedland JS; Ho BCH; Ippolito G; Jankovic M; Kim HY; Rosales Klintz S; Ködmön C; Lalle E; Leo YS; Leung CC; Märtson AG; Melazzini MG; Najafi Fard S; Penttinen P; Petrone L; Petruccioli E; Pontali E; Saderi L; Santin M; Spanevello A; van Crevel R; van der Werf MJ; Visca D; Viveiros M; Zellweger JP; Zumla A; Goletti D
    Eur Respir J; 2020 Oct; 56(4):. PubMed ID: 32586885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring the perspectives of members of international tuberculosis control and research networks on the impact of COVID-19 on tuberculosis services: a cross sectional survey.
    Nkereuwem O; Nkereuwem E; Fiogbe A; Usoroh EE; Sillah AK; Owolabi O; Tebruegge M; Badjan A; Kampmann B; Togun T
    BMC Health Serv Res; 2021 Aug; 21(1):798. PubMed ID: 34384439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triple Burden: The Incorrigible Threat of Tuberculosis, HIV, and COVID-19.
    Gupta P; Sandhu D; Gupta V; Singhal L
    Infect Disord Drug Targets; 2024; 24(4):1-7. PubMed ID: 37937570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.